Pillstats
OTC · Powder, For Suspension · Oral

Polyethylene Glycol

Polyethylene Glycol 3350

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)221147
US makers1 labelers
Packages2
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.007$0.013$0.020$0.026Dec 2025Apr 2026Jul 2026
$0.022
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

16K31K47K62K2025 Q12025 Q22025 Q32025 Q42026 Q1
54K
Rx · 2026 Q1
23.8M
Units dispensed
+71%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
BluePoint Laboratoriesunknown2SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.